FDA Inspection 1326648 — The American National Red Cross Diagnostic Manufacturing Division
The FDA completed an inspection of The American National Red Cross Diagnostic Manufacturing Division on Jul 10, 2026 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 10, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gaithersburg, MD (United States)